[go: up one dir, main page]

EP3573612A4 - Utilisation d'acides gras à chaîne courte pour le traitement et la prévention de maladies et de troubles - Google Patents

Utilisation d'acides gras à chaîne courte pour le traitement et la prévention de maladies et de troubles Download PDF

Info

Publication number
EP3573612A4
EP3573612A4 EP18744902.0A EP18744902A EP3573612A4 EP 3573612 A4 EP3573612 A4 EP 3573612A4 EP 18744902 A EP18744902 A EP 18744902A EP 3573612 A4 EP3573612 A4 EP 3573612A4
Authority
EP
European Patent Office
Prior art keywords
disorders
diseases
prevention
treatment
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18744902.0A
Other languages
German (de)
English (en)
Other versions
EP3573612A1 (fr
Inventor
Ira C. SPECTOR
Mark A. Feitelson
Alla ARZUMANYAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple Univ School of Medicine
Original Assignee
Temple Univ School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple Univ School of Medicine filed Critical Temple Univ School of Medicine
Priority claimed from PCT/US2018/015383 external-priority patent/WO2018140687A1/fr
Publication of EP3573612A1 publication Critical patent/EP3573612A1/fr
Publication of EP3573612A4 publication Critical patent/EP3573612A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP18744902.0A 2017-01-27 2018-01-26 Utilisation d'acides gras à chaîne courte pour le traitement et la prévention de maladies et de troubles Pending EP3573612A4 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762451192P 2017-01-27 2017-01-27
US201762510867P 2017-05-25 2017-05-25
US201762530371P 2017-07-10 2017-07-10
US201762539572P 2017-08-01 2017-08-01
US201762588961P 2017-11-21 2017-11-21
PCT/US2018/015383 WO2018140687A1 (fr) 2017-01-27 2018-01-26 Utilisation d'acides gras à chaîne courte pour le traitement et la prévention de maladies et de troubles

Publications (2)

Publication Number Publication Date
EP3573612A1 EP3573612A1 (fr) 2019-12-04
EP3573612A4 true EP3573612A4 (fr) 2020-11-18

Family

ID=68342291

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18744902.0A Pending EP3573612A4 (fr) 2017-01-27 2018-01-26 Utilisation d'acides gras à chaîne courte pour le traitement et la prévention de maladies et de troubles

Country Status (1)

Country Link
EP (1) EP3573612A4 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735967A (en) * 1985-05-28 1988-04-05 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
US20080107646A1 (en) * 2002-04-26 2008-05-08 Yih-Lin Chung Method for ameliorating pruritus
WO2011137173A1 (fr) * 2010-04-28 2011-11-03 The Chinese University Of Hong Kong Procédé et médicament pour la prévention et le traitement de l'hypertension oculaire et du glaucome
WO2012013495A1 (fr) * 2010-07-29 2012-02-02 Cosmo Technologies Ltd. Compositions pharmaceutiques et/ou alimentaires à base d'acides gras à chaîne courte
WO2012131069A1 (fr) * 2011-03-31 2012-10-04 Proponent Biotech Gmbh Acides gras à chaîne courte et leurs dérivés à utiliser dans le traitement de troubles immunogènes
US20160136122A1 (en) * 2014-10-16 2016-05-19 Jose U. Scher Methods for treating psoriatic arthritis

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735967A (en) * 1985-05-28 1988-04-05 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
US20080107646A1 (en) * 2002-04-26 2008-05-08 Yih-Lin Chung Method for ameliorating pruritus
WO2011137173A1 (fr) * 2010-04-28 2011-11-03 The Chinese University Of Hong Kong Procédé et médicament pour la prévention et le traitement de l'hypertension oculaire et du glaucome
WO2012013495A1 (fr) * 2010-07-29 2012-02-02 Cosmo Technologies Ltd. Compositions pharmaceutiques et/ou alimentaires à base d'acides gras à chaîne courte
WO2012131069A1 (fr) * 2011-03-31 2012-10-04 Proponent Biotech Gmbh Acides gras à chaîne courte et leurs dérivés à utiliser dans le traitement de troubles immunogènes
US20160136122A1 (en) * 2014-10-16 2016-05-19 Jose U. Scher Methods for treating psoriatic arthritis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EEF BOETS ET AL: "Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study : Short-chain fatty acid systemic availability and metabolism in humans", THE JOURNAL OF PHYSIOLOGY, vol. 595, no. 2, 18 September 2016 (2016-09-18), GB, pages 541 - 555, XP055694009, ISSN: 0022-3751, DOI: 10.1113/JP272613 *
See also references of WO2018140687A1 *
VEALE D J: "Immunopathology of psoriasis and psoriatic arthritis", ANNALS OF THE RHEUMATIC DISEASES, vol. 64, no. suppl_2, 1 March 2005 (2005-03-01), GB, pages ii26 - ii29, XP093096447, ISSN: 0003-4967, Retrieved from the Internet <URL:https://ard.bmj.com/content/annrheumdis/64/suppl_2/ii26.full.pdf> DOI: 10.1136/ard.2004.031740 *

Also Published As

Publication number Publication date
EP3573612A1 (fr) 2019-12-04

Similar Documents

Publication Publication Date Title
EP3837359A4 (fr) Méthodes et compositions pour le traitement d&#39;une maladie mitochondriale ou de troubles mitochondriaux et hétéroplasmie
EP3490603A4 (fr) Compositions et procédés d&#39;inhibition de masp-3 pour le traitement de maladies et troubles divers
EP3826666A4 (fr) Compositions et méthodes de traitement de maladies associées à la nrp2
EP3672594A4 (fr) Produit de combinaison d&#39;inhibiteur de bcl -2 et d&#39;inhibiteur de mdm2, et utilisation de ce dernier dans la prévention et/ou le traitement de maladies
EP3609515A4 (fr) Procédés pour le traitement d&#39;une inflammation et d&#39;affections inflammatoires
EP3507371A4 (fr) Méthodes et compositions pour traiter des maladies et des troubles du système nerveux
EP3880304C0 (fr) Compositions pour le traitement de maladies cutanées associées au stress oxydatif et du vieillissement de la peau
EP3737692A4 (fr) Constructions de liaison à la calréticuline et lymphocytes t modifiés pour le traitement de maladies
EP3969597A4 (fr) Compositions et procédés pour le traitement de maladies médiées par l&#39;atpase
EP3592345A4 (fr) Compositions et méthodes pour le traitement de maladies inflammatoires
EP3716972A4 (fr) Immunomodulateurs à base de pyranopyrazole et de pyrazolopyridine pour le traitement de maladies auto-immunes
EP3741747C0 (fr) Procédé de prévention et/ou de traitement de l&#39;anxiete
EP3701048C0 (fr) Procédés et compositions pour évaluer et traiter des maladies et des troubles intraoculaires
EP3836965A4 (fr) Compositions et procédés d&#39;inhibition de masp-2 pour le traitement de divers troubles et maladies thrombotiques
EP3583113A4 (fr) Utilisation de tgf-alpha pour le traitement de maladies et de troubles
EP3715349A4 (fr) Composé bisdiazabicyclo pour le traitement et/ou la prévention de maladies ou de troubles liés au virus de l&#39;hépatite
EP3976020A4 (fr) Acides gras à très longue chaîne pour le traitement et le soulagement de maladies
EP3902605A4 (fr) Méthodes et compositions pour traiter des troubles cutanés et capillaires
EP3664789A4 (fr) Méthodes de traitement de maladies et de lésions des nerfs
EP3675871A4 (fr) Compositions et méthodes de traitement de maladies fibrotiques
EP3681871A4 (fr) Compositions et procédés pour le traitement d&#39;une lésion cérébrale
EP3849591A4 (fr) Méthodes et compositions pour traiter des maladies de la peau
EP3720493C0 (fr) Combinaisons d&#39;inhibiteurs de ripk1 et d&#39;ikk pour la prévention ou le traitement de maladies immunitaires
EP3395341C0 (fr) Composition pour le traitement de maladies neuromotrices et son utilisation
EP3979996A4 (fr) Méthodes et compositions de traitement de troubles de la vue

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190812

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20201021

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20201015BHEP

Ipc: A61K 31/19 20060101AFI20201015BHEP

Ipc: A61P 17/06 20060101ALI20201015BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230327